FIR FirMeApp icon

v3.3.3 by Quizit Mobile


Mar 8, 2019

About FIR FirMeApp

Prepare the FIR with FirMeApp, tests, questions, tests and assignments of FIR

FIR MeApp is your application for the FIR preparte opposition.

FirMeApp is a free application that allows you to review what you're studying for your preparation for the opposition Pharmaceutical Resident Intern, FIR, anytime, anywhere easily.

Includes all questions and answers FIR official exams test since 2003-2017.

You can:

- Check the test from the beginning, or check the results once this.

- 'See' the right answer at any time with the eye-shaped icon.

- Entering a ranking and go upscale.

- Share questions by Whatsapp or mail.

- Save the questions you there is any doubt or controversy favorites.

- Stop and continue testing at any time.

- Check the time you spend on each test to do your homework as faithful as possible to the actual conditions of the FIR.

- Wear comfortable control the results of your tests and drills.

Use FirMeApp check the results in the preparation of FIR. If you like the app and you find it helpful Rate it and comment it so we can improve the application so that it can tell you the most profitable.

You can also propose changes or improvements in our mail: [email protected]

What's New in the Latest Version v3.3.3

Last updated on Mar 8, 2019

Actualizada con el examen de 2018. Estábamos por poner también el de 2019 pero iba a ser mucho descaro...

Translation Loading...

Additional APP Information

Latest Version

Request FIR FirMeApp Update v3.3.3

Uploaded by

Emeel Nageeb

Requires Android

Android 4.1+

Show More

FIR FirMeApp Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.